切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Renin - FPTase - CSF1R - PKG - Topoisomerases

24件产品中的 1-10

页面
每页
清除全部
  1. Pexidartinib (PLX3397)
    B5854 Pexidartinib (PLX3397)
     3 Citation
    中文名: 培西达替尼
    Target: FLT3|c-Kit|CSF1R
    Summary: CSF-1R抑制剂
      ≥20.9 mg/mL
      insoluble in H2O
  2. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  3. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 蛋白激酶抑制剂
      Soluble in DMSO
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Fasudil
    B3523 Fasudil
    中文名: 法舒地尔
    Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 钙拮抗剂
      Soluble in DMSO
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. Aliskiren Hemifumarate
    B2215 Aliskiren Hemifumarate
    中文名: 阿利克仑半富马酸盐
    Target: Renin
    Summary: 肾素抑制剂
      ≥58.5 mg/mL
      ≥122 mg/mL
  10. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O

24件产品中的 1-10

页面
每页